共 161 条
- [11] Polo JR(2004)Quantifying bacterial bioburden during negative pressure wound therapy:does the wound VAC enhance bacterial clearance? Ann Plast Surg 52 276-279
- [12] Bouza E(1997)Aerobic, anaerobic and fungal burn wound infections J Hosp Infect 37 317-323
- [13] Stiller MJ(2003)Immunoparalysis as a cause for invasive aspergillosis? Intens Care Med 29 2068-2071
- [14] Teperman L(1990)Amphotericin B:30 years of clinical experience Rev Infect Dis 12 308-329
- [15] Rosenthal SA(2004)Voriconazole for serious fungal infections Int J Clin Pract 58 74-80
- [16] Riordan A(2004)New antifungal agents Semin Respir Crit Care Med 25 233-239
- [17] Potter J(2005)Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study J Infect 50 196-205
- [18] Shupack JL(2005)Antifungal combination therapy: clinical potential Drugs 65 1461-1480
- [19] Gordon MA(2005)Successful antifungal combination therapy with voriconazole and caspofungin Pediatr Blood Cancer 44 682-685
- [20] Doffman SR SG(2005)Necrotizing fasciitis:pathogenesis and treatment Expert Rev Anti Infect Ther 3 279-294